Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2025-01-27

Clinical Trial Update: Study to Evaluate the Safety and Efficacy of Teropavimab and Zinlirvimab in Combination With Lenacapavir in Virologically Suppressed Adults With HIV-1 Infection [Phase 1]

View source ↗

Summary

Phase 1 study assessing safety and preliminary efficacy of teropavimab and zinlirvimab with lenacapavir in virologically suppressed adults with HIV-1; study com…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Lenacapavir (lenacapavir)
  • Teropavimab (teropavimab)
  • Zinlirvimab (zinlirvimab)

Snippet

Sponsor: Gilead Sciences | Conditions: HIV-1 Infection | Phase 1 | Status: COMPLETED | Results posted: 2025-01-27